Top 10 Biotechnology Angel Investors in Belgium in January 2026
A list of 10 angel investors that invest in Biotechnology startups based in Belgium. We rank investors based on the number of investments they made in Biotechnology companies from Belgium. We update this investor list every month.Top 10 Biotechnology Angel Investors in Belgium in January 2026
| Investor | Biotechnology Belgium investments |
|---|---|
| Pierre Drion | 3 |
| Annie Vereecken | 3 |
| Luc Vauterin | 2 |
| Herman Verrelst | 1 |
| Evren Ucok | 1 |
| Jean Dessain | 1 |
| Yves Beudin | 1 |
| Virginie Saverys | 1 |
| Patrick Keereman | 1 |
| Kenneth Buckfire | 1 |
Pierre Drion - CEO @ Petercam
Show more
Investment focus
- Biotechnology, Health Care, Life Science
- Series A, Series B, Funding Round
- Belgium
Portfolio highlights
- A-Mansia Biotech — A-Mansia Biotech is a developer of products based on the properties of the Akkermansia muciniphila (A. muciniphila) bacterium. The company's nutritional supplement based on a gut bacterium called Akkermansia, the population of microorganisms housed in the gastrointestinal tract. A. muciniphila is located in the mucus layer covering theintestinal epithelium, which allows the bacterium to establish a close cross-talk with the host.
- Novadip Biosciences — Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.
- Santero Therapeutics — This is the homepage of the website
Annie Vereecken
Show more
Investment focus
- Biotechnology, Medical, Hospital
- Seed, Series A, Funding Round
- Belgium
Portfolio highlights
- Ziphius — Ziphius Vaccines is a biopharmaceutical company dedicated to developing next-generation vaccines for the prevention of infectious diseases.
- Sensolus — Sensolus provides care-free tracking of your valuable non-powered assets directly from the cloud.Sensolus offers turnkey solutions for wireless, low-power context-aware sensing. Sensolus developed a personal product line of low-power tracker systems called STICKNTRACK.Sensolus is built upon many years of expertise in low-power networks,wireless sensor design, cloud-based sensor management, analytics, and applications.
- Allegro Biotech — Allegro has developed the world’s-first custom-tailored, durable, biocompatible, anisotropic, regenerative meniscus cartilage, providing immediate support while also leverage the body’s own healing potential to regenerate human cartilage (proliferation and differentiation of fibrochondrocyte cells).
Luc Vauterin - Board Member @ ONTOFORCE
Show more
Investment focus
- Life Science, Data Integration, Data Visualization
- Seed, Series A
- Belgium
Portfolio highlights
- ONTOFORCE — ONTOFORCE creates and implements pioneering semantic search technology for information management. Our user-friendly data search platform DISQOVER builds uniquely intelligent links between heterogeneous data sources, allowing everybody to become a data scientist.
Herman Verrelst
Show more
Investment focus
- Medical, Hospital, Biotechnology
- Series A
- Belgium
Portfolio highlights
- UgenTec — FastFinder is intelligent software that automates sample workflow, ensures your assays are analyzed consistently and cuts data analysis time in half.
Evren Ucok is a co-founder and investor at Peak Games, an interactive social game development platform.
He is also a partner at Earlybird Venture Capital, an investment fund-based in Europe that focuses on emerging companies; Trendyol.com, a fashion e-commerce site; and Oliver Wyman.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Turkey, Belgium
Portfolio highlights
- idemama — Idemama is an online platform that provides its users with web and graphic design services. It is based in Istanbul, Turkey.
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Jean Dessain - Non Executive Director @ OneLIFE
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Yves Beudin
Show more
Investment focus
- Medical, Health Care, Biotechnology
- Angel
- Belgium
Portfolio highlights
- OneLIFE — Enzymatic cleaning solutions against soiling and biofilms for medical devices and the hospital environment. Safe for staff, patients and visitors.
Virginie Saverys is a entrepreneur.
Show more
Investment focus
- Medical, Life Science, Biotechnology
- Seed
- Belgium
Portfolio highlights
- 4Tissue — Shaping the Future of Regenerative Medicine
Patrick Keereman
Show more
Investment focus
- Medical, Hardware, Software
- Seed
- Belgium
Portfolio highlights
- MOLECUBES — MOLECUBES is a Ghent University spin-off started with the support of iMinds. Springing from the MEDISIP research group and the preclinical INFINITY lab, a team of young hardware and software engineers with hands-on experience grouped together to make a difference in their and your daily imaging practice.We build preclinical imaging cubesallowing you to combine SPECT, PET and CT imaging in almost any lab space. Modular systems leave full flexibility at your side while ensuring full mice and full rat imaging. Intuitive wireless acquisition and reconstruction software allow the systems to be used almost anywhere by anyone. Being built by end-users we also understand the importance of good servicing.
Kenneth Buckfire is the Chief Executive Officer at Miller Buckfire.
Show more
Investment focus
- Medical, Health Care, Life Science
- Series A
- Belgium
Portfolio highlights
- Amyl Therapeutics — Amyl Therapeutics is a preclinical stage biotechnology company. Amyl Therapeutics uses a novel mechanism to bind to the amyloid fold of toxic protein aggregates of various types, including antibody light chain (AL) or transthyretin (TTR) aggregates, which accumulate in peripheral organs to cause systemic amyloidosis diseases, but also amyloid-β(Aβ), Tau, and α-synuclein aggregates, which accumulate in the brain to cause Alzheimer's and Parkinson's diseases.
Investors by industry
Community
Artificial intelligence
Hardware
Marketplace
Consumer
FinTech
Energy
Gaming
EdTech
Sustainability
Impact
Venture Capital
Clean Energy
Climate
Proptech
Web3
Google
Organic Food
Biotech
Big Data
Video Games
Health Care
Publishing
Art
B2B
Food and Beverage
Wellness
Payments
Android
Real Estate
Finance
Digital Media
Education
Manufacturing
Financial Services
Retail
Construction
Infrastructure
Sports
Franchise
Beauty
eSports
Photography
Mobile
Biotechnology
Enterprise Software
Travel
Music
Email
Fitness
Social Media
Recruiting
Social Network
Hospitality
Medical
Mobile Advertising
Legal
Platforms
Cannabis
Local
Automotive
Internet
Social
CleanTech
Wine And Spirits
Medical Device
Mobile Apps
Crowdfunding
Transportation
InsurTech
Enterprise
Film
LGBT
Oil and Gas
Fashion
Life Science
Non Profit
Theatre
Renewable Energy
SaaS
Sporting Goods
Software
Restaurants
Social Impact
Celebrity
Agriculture (agtech)
Cryptocurrency
Machine Learning
Media (entertainment)
Facebook
Blockchain
Investors by country
New Zealand
Ireland
Canada
United States
India
Germany
United Kingdom
South Korea
Middle East
Indonesia
Australia
South Africa
Sri Lanka
Ghana
Vietnam
Europe
Egypt
Qatar
Japan
Singapore
Belarus
Hungary
Spain
China
Armenia
Finland
Saudi Arabia
France
Oceania
Africa
Croatia
LATAM
Asia
Gibraltar
Brazil
Liechtenstein
Barbados
Georgia
Panama
Greece
Myanmar
Lithuania
Czech Republic
Malaysia
Faroe Islands
Costa Rica
Peru
Hong Kong
Liberia
Jersey
Lebanon
Norway
Bahrain
Mexico
Belgium
Italy
Denmark
Mali
Philippines
Bermuda
Estonia
Israel
Kuwait
Algeria
Mauritius
Ecuador
Malta
Morocco
Bulgaria
Nicaragua
Togo
Belize
Rwanda
Chile
Slovenia
Poland
Uganda
Ethiopia
Dominican Republic
Bahamas
San Marino
Sweden
Serbia
Iraq
Iceland
Sierra Leone
Thailand
Azerbaijan
Tanzania
Nigeria
Uzbekistan
Zambia
Namibia
United Arab Emirates
Turkey
Jamaica
Honduras
Uruguay
Isle of Man
Bolivia
Luxembourg
Tajikistan
Russian Federation
Pakistan
Portugal
Albania
Romania
El Salvador
Puerto Rico
Jordan
Senegal
Grenada
Argentina
Zimbabwe
Tunisia
Bangladesh
Venezuela
Kenya
Ukraine
Taiwan
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Seychelles
Angel Investors in Belgium by industry
Biotechnology
Marketplace
Food and Beverage
Financial Services
Big Data
Finance
Life Science
Medical
Medical Device
Internet
Social Media
Manufacturing
Software
Sports
Enterprise Software
Mobile Advertising
Hospitality
Automotive
FinTech
Enterprise
Health Care
Biotech
SaaS
Climate
Community
Gaming
Real Estate
Transportation
Publishing
Retail
Legal
Platforms
Proptech
Payments
Artificial intelligence
Hardware
Construction
Media (entertainment)
Machine Learning
Energy
Consumer
Mobile